Status:
UNKNOWN
The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
COVID
Pneumonia, Viral
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing...
Detailed Description
Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing...
Eligibility Criteria
Inclusion
- All patients with an informed consent
- Admission to emergency department with symptoms or signs of COVID-19
Exclusion
- Absence of informed consent
- Patients under age of 18
- Presence of acute coronary syndrome
- Presence of chronic lung disease
- Pregnancy
- Presence of trauma
- Patients with a diagnosis of malignancy
Key Trial Info
Start Date :
May 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 10 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04399681
Start Date
May 10 2020
End Date
September 10 2020
Last Update
May 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Turkey (Türkiye), 34303